June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Uveal Lymphoma: Comparison of Diagnostic Imaging Studies
Author Affiliations & Notes
  • Mary Aronow
    Cole Eye Institute, Cleveland Clinic, Shaker Heights, OH
  • Craig Portell
    Hematologic Oncology and Blood Disorders, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH
  • John Sweetenham
    Hematologic Oncology and Blood Disorders, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH
  • Arun Singh
    Cole Eye Institute, Cleveland Clinic, Shaker Heights, OH
  • Footnotes
    Commercial Relationships Mary Aronow, None; Craig Portell, None; John Sweetenham, None; Arun Singh, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 5878. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Mary Aronow, Craig Portell, John Sweetenham, Arun Singh; Uveal Lymphoma: Comparison of Diagnostic Imaging Studies. Invest. Ophthalmol. Vis. Sci. 2013;54(15):5878.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

To compare imaging results from fluorescein angiography (FA), indocyanine green angiography (ICG), B-scan ultrasonography, computed tomography (CT), and magnetic resonance imaging (MRI) in patients with uveal lymphoma.

 
Methods
 

Data were collected regarding patient characteristics, clinical features on ophthalmic examination, and ancillary imaging studies in 16 patients (25 affected eyes) diagnosed with uveal lymphoma between 1997 and 2012.

 
Results
 

12 patients were male (75.0%) and the median age at diagnosis was 67.5 years. Choroidal involvement was present in 15 (93.7%) and ciliochoroidal disease was present in 1 (6.3%) case. Lymphoma of overlapping ocular adnexal structures was observed in 8 cases (50.0%) including: the conjunctiva in 4 (25.0%), the orbit in 3 (17.7%), and conjunctiva and orbit in 1 (6.3%) case. Bilateral disease was present in 9 cases (56.3%). The most characteristic clinical examination finding was yellow-white choroidal infiltrates, observed in 25 (100.0%) eyes. Infiltrates were located anterior to the arcades (84.0%), most commonly in a diffuse (32.0%) or superotemporal (32.0%) distribution. FA yielded a variety of patterns including early hyperfluorescence (84.6%), hypofluorescent lesions (15.4%), choroidal folds (38.5%), and normal angiographic findings (7.7%). In contrast, ICG demonstrated hypofluorescent lesions corresponding to clinically observed infiltrates in 100% of cases. B-scan ultrasonography detected extrascleral extension (ESE) in 70% of eyes. In such cases, CT orbit detected 25.0% and MRI orbit detected 75.0% of eyes with ESE.

 
Conclusions
 

Ancillary imaging is essential for evaluating the full extent of ocular involvement and for treatment planning in individuals with uveal lymphoma. ICG is a superior imaging study than FA to assess choroidal lymphoma. B-scan ultrasonography is more sensitive in detecting ESE than either CT or MRI of the orbit.

 
Keywords: 744 tumors • 745 uvea  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×